DK3278811T3 - Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade - Google Patents

Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade Download PDF

Info

Publication number
DK3278811T3
DK3278811T3 DK17187879.6T DK17187879T DK3278811T3 DK 3278811 T3 DK3278811 T3 DK 3278811T3 DK 17187879 T DK17187879 T DK 17187879T DK 3278811 T3 DK3278811 T3 DK 3278811T3
Authority
DK
Denmark
Prior art keywords
ggf2
treatment
peripheral nervous
neuropatic pain
nervous injury
Prior art date
Application number
DK17187879.6T
Other languages
Danish (da)
English (en)
Inventor
Anthony O Caggiano
Anthony J Bella
Anindita Ganguly
Jennifer Iaci
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Application granted granted Critical
Publication of DK3278811T3 publication Critical patent/DK3278811T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1883Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK17187879.6T 2012-03-30 2013-03-29 Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade DK3278811T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693585P 2012-08-27 2012-08-27
US201261693589P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
EP13716919.9A EP2830645B1 (en) 2012-03-30 2013-03-29 Neuregulin for use in treating peripheral nerve injury

Publications (1)

Publication Number Publication Date
DK3278811T3 true DK3278811T3 (da) 2021-03-01

Family

ID=48128617

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17187879.6T DK3278811T3 (da) 2012-03-30 2013-03-29 Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade
DK13716919.9T DK2830645T3 (da) 2012-03-30 2013-03-29 Neuregulin til anvendelse i behandling af perifær nervelæsion

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK13716919.9T DK2830645T3 (da) 2012-03-30 2013-03-29 Neuregulin til anvendelse i behandling af perifær nervelæsion

Country Status (15)

Country Link
US (3) US20150094263A1 (enExample)
EP (3) EP2830645B1 (enExample)
JP (4) JP6420233B2 (enExample)
CN (2) CN104321072A (enExample)
AU (4) AU2013237896B2 (enExample)
BR (1) BR112014024308B1 (enExample)
CA (1) CA2869070A1 (enExample)
DK (2) DK3278811T3 (enExample)
ES (2) ES2647917T3 (enExample)
IL (3) IL288785B2 (enExample)
MX (1) MX354598B (enExample)
NZ (1) NZ700546A (enExample)
PL (2) PL3278811T3 (enExample)
PT (2) PT2830645T (enExample)
WO (1) WO2013149163A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3338791T3 (da) 2008-07-17 2019-12-16 Acorda Therapeutics Inc Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt
PL3235504T3 (pl) 2009-10-14 2020-03-31 Acorda Therapeutics, Inc. Zastosowanie neureguliny do leczenia uszkodzenia nerwu obwodowego
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
IL294038A (en) * 2015-12-04 2022-08-01 Univ Iowa Res Found Device, systems and methods for prediction, screening and monitoring of encephalopathy / delirium
CA3082878C (en) 2017-11-17 2024-02-20 The Research Foundation for State University of New York A method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
CN114929099B (zh) * 2019-08-01 2025-08-15 马克·埃文斯 用于在分娩期间和分娩之前降低人类胎儿神经损伤风险及鉴定神经损伤存在的方法和设备
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US888A (en) 1838-08-20 perkins
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
EP1028735A4 (en) * 1997-10-14 2003-08-06 Cenes Pharmaceuticals Inc THERAPEUTIC METHOD COMPRISING THE USE OF NEUREGULIN
CA2409996C (en) * 2000-05-23 2016-03-01 Cenes Pharmaceuticals, Inc. Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2009046453A2 (en) * 2007-10-05 2009-04-09 New England Medical Center (Nemc) Use of neuregulin-1 in reducing brain damage
CN104645315A (zh) * 2008-02-29 2015-05-27 阿索尔达治疗公司 达到所需胶质生长因子2血浆水平的方法
DK3338791T3 (da) * 2008-07-17 2019-12-16 Acorda Therapeutics Inc Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt
KR101237927B1 (ko) * 2009-05-07 2013-03-04 (주)문엔제이 신경손상 및 신경질환 예방 또는 치료용 약학조성물
PL3235504T3 (pl) * 2009-10-14 2020-03-31 Acorda Therapeutics, Inc. Zastosowanie neureguliny do leczenia uszkodzenia nerwu obwodowego
CA2845198A1 (en) * 2010-08-13 2012-02-16 Georgetown University Ggf2 and methods of use

Also Published As

Publication number Publication date
JP7108724B2 (ja) 2022-07-28
PT3278811T (pt) 2021-03-03
EP3278811B1 (en) 2020-12-02
EP3842059A1 (en) 2021-06-30
EP2830645B1 (en) 2017-08-30
IL234882B (en) 2020-03-31
ES2647917T3 (es) 2017-12-27
HK1249038A1 (en) 2018-10-26
CN104321072A (zh) 2015-01-28
JP2021059605A (ja) 2021-04-15
IL273186B (en) 2022-01-01
AU2018200592A1 (en) 2018-02-15
JP6420233B2 (ja) 2018-11-07
CA2869070A1 (en) 2013-10-03
MX354598B (es) 2018-03-12
HK1206632A1 (en) 2016-01-15
PL3278811T3 (pl) 2021-08-02
US20230117985A1 (en) 2023-04-20
IL273186A (en) 2020-04-30
PL2830645T3 (pl) 2018-01-31
BR112014024308A2 (pt) 2017-08-08
IL288785A (en) 2022-02-01
IL234882A0 (en) 2014-12-31
AU2013237896A1 (en) 2014-10-16
AU2019202401A1 (en) 2019-05-02
EP2830645A1 (en) 2015-02-04
JP2019131582A (ja) 2019-08-08
EP3278811A1 (en) 2018-02-07
JP2015514096A (ja) 2015-05-18
AU2019202401B2 (en) 2020-10-15
AU2013237896B2 (en) 2017-11-02
BR112014024308B1 (pt) 2021-11-30
DK2830645T3 (da) 2017-11-20
CN106511971A (zh) 2017-03-22
BR112014024308A8 (pt) 2018-01-23
US20160346353A1 (en) 2016-12-01
PT2830645T (pt) 2017-11-28
AU2020260539A1 (en) 2020-11-26
MX2014011838A (es) 2015-03-09
WO2013149163A1 (en) 2013-10-03
ES2857810T3 (es) 2021-09-29
US20150094263A1 (en) 2015-04-02
NZ700546A (en) 2017-05-26
JP2017149746A (ja) 2017-08-31
IL288785B (en) 2022-11-01
IL288785B2 (en) 2023-03-01

Similar Documents

Publication Publication Date Title
DK2836200T3 (da) Termoreversible hydrogelpræparater til anvendelse i behandlingen af lidelser i urothelium
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DK3815684T3 (da) Fremgangsmåder til at reducere risikoen for en kardiovaskulær hændelse i en person i statinbehandling
DK2883104T3 (da) Anvendelse af kontaktlinse ved behandling af en ofthalmologisk lidelse
DK3278811T3 (da) Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
EP2755676A4 (en) COMPOSITION AND ASSOCIATION FOR WOUND TREATMENT
DK3307262T3 (da) Forbindelser til anvendelse ved behandling af neuromuskulære lidelser
DK3542798T3 (da) Aceclidin til brug ved behandling af presbyopi
EP2868283A4 (en) THERAPEUTIC TREATMENT DEVICE
DK2830662T3 (da) Fremgangsmåder til behandlng af hårtabsforstyrrelser
EP2906208A4 (en) THERAPEUTIC TREATMENT
IL263661A (en) Combination therapy for the treatment of glioblastoma
SG11201500685PA (en) Warm-cool beauty treatment device
PT2709604T (pt) Canabidivarina para utilização no tratamento de dor neuropática
IL238027A0 (en) 2-phenyl-5-heterocyclyl-tetrahydro-h2-pyran-3-amine compounds for use in the treatment of diabetes and related disorders
DK2747763T3 (da) (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser
PL2838539T3 (pl) Składniki estrogenowe do zastosowania w leczeniu zaburzeń neurologicznych
DK2844279T3 (da) Doseringsprogrammer til behandling af pompes sygdom
DK3040336T3 (da) Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande
DK2827813T3 (da) Kuldebehandlingsindretning
DK2782566T3 (da) L-serin til anvendelse ved behandling af neurodegenerative lidelser
EP2939625A4 (en) THERAPEUTIC TREATMENT DEVICE
DK2818241T3 (da) Fremgangsmåde til fremstilling af behandlingsapparat udstyret med katalysatorbærende honeycombstruktur